ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

HBF Reports and Publications

The Hepatitis B Foundation and Blumberg Institute regularly produce reports and manuscripts about work toward the elimination and prevention of hepatitis B and related scientific advances. Below on this page are selected recent reports.

A selection of recent, peer-reviewed journal articles and other scholarly publications that were written by 
Hepatitis B Foundation public health researchers and collaborators are posted here.

The Foundation's annual reports are posted here.

Journal articles recommended by our Emerging Scholars Scientific and Medical Advisory Board, which is a new service, are posted here.

A selection of White Papers and other special reports that were written by Hepatitis B Foundation public health researchers and collaborators are posted below.

Hepatitis B Foundation releases white paper calling health care providers into action following new hepatitis B screening and vaccination recommendations (2023)
With the U.S. Centers for Disease Control and Prevention (CDC) March 10, 2023, release of new guidance for hepatitis B screening, adding to updated recommendations on vaccination that the CDC put out in 2022, the Hepatitis B Foundation produced a white paper with guidance on how health care providers in the U.S. can begin implementing these new universal hepatitis B screening and vaccination (for adults ages 19-59) guidelines. Please read more here.

Recommendations for Expanding Hepatitis B Screening and Prevention in Corrections: A White Paper by the Hepatitis B Foundation (2023), Hepatitis B Foundation
People who are incarcerated in the U.S. rarely receive the education, testing, and vaccination necessary to prevent hepatitis B transmission. The fragmented nature of the correctional healthcare system and lack of standardized and updated hepatitis B recommendations hinder the ability of correctional healthcare staff to improve hepatitis B screening and vaccination practices in their facilities. Please read more here.

Opportunities for Federal-Community Collaboration to Reduce Disparities in Hepatitis B: 2014-2016Hep B United (2020) 
The purpose of this document is to identify areas where Hep B United and other community-based coalitions can work with federal agencies and within their local coalition to further the priority areas identified in the U.S. Department of Health and Human Services.

Roadmap for a CureHepatitis B Foundation (2017)
This report provides an overview of our research agenda, with information on priority research areas and potential funding.

Hepatitis B Foundation and FDA Meeting ReportHepatitis B Foundation (2017)
Representatives from the Hepatitis B Foundation and HBV Forum met with representatives from the US FDA in March 2017 to discuss clinical development of hepatitis B therapeutics.